SUMMARY Sixty-one patients with ocular hypertension (1 17 eyes) were followed up for I to 11 years (average 40 7 months). Ten 
Screening programmes to detect raised intraocular pressure (IOP) are widely used because of increasing awareness of both ophthalmologists and the general population of the symptomless presentation and progression of chronic open-angle glaucoma. After careful examination of those with raised intraocular pressure an ever growing group of patients is emerging who, in spite of a raised intraocular pressure, show neither pathological cupping of the optic disc nor a glaucomatous visual field defect. These patients are labelled 'ocular hypertensives'.
The incidence of ocular hypertension (OHT) in the general population is variously reported as 10%
in the Oxford survey (Luntz et al., 1963) , 1-3 % in the Birmingham study (Walker, 1974) , and 50% in the Bedford survey (Perkins, 1973b) . This is about five times higher than the incidence of glaucoma in the latter two studies (0 31 % in the Birmingham study and 0930% in the Bedford survey (Bankes et al., 1968) ). The incidence in a glaucoma clinic population is much higher-according to one report 11 0% (Luntz, 1972) . Some authors believe that ocular hypertension represents a preglaucomatous stage (Richardson, 1972; and Goldmann, 1959) . Others report on varying degrees of risk of patients with ocular hypertension for developing glaucoma. Graham (1968) and Armaly (1969) found it as low as 0.5%, Linner and Stromberg (1967) 2%, Perkins (1973a) 3-23%, and Walker (1974) as high as 20%. Kass et al. (1976) 
Definition of criteria
Patients attending our glaucoma clinics were diagnosed as OHT if: (1) The untreated intraocular pressure is found to be 21 mmHg or more on repeated measurements with the Goldmann applanation tonometer (Graham, 1972) . The mean value of 3 pressures measured within the first few weeks of the patient's presenting to hospital is referred to in this paper as 'the mean initial intraocular pressure'. (2) The visual fields are normal when tested both with the Goldmann perimeter and the Bjerrum tangent screen. (3) The optic cup is separated from the edge of the disc by pink-coloured normal tissue (Drance, 1975) . (4) There is no excavation of the disc margin by the optic cup. (5) The filtration angle is open.
Material and methods
A total of 61 patients (117 eyes) with ocular hypertension have been followed for 1 to 11 years. All the patients attend the glaucoma clinics at the Johannesburg General Hospital and at the St. John Eye Hospital, Baragwanath. Fifty-six patients had bilateral ocular hypertension, 3 others unilateral ocular hypertension, the other eye being normal, and 2 patients had ocular hypertension in an only eye, the fellow eye being blind from disease other than glaucoma.
After the diagnosis of ocular hypertension is made-on the criteria mentioned above-the patients are reassessed at intervals of 2 to 6 months; intraocular pressure is measured at every visit and the optic disc examined by uniocular and binocular fundoscopy. In all our cases the field defect could be correlated to a corresponding area of pathological cupping at the disc.
For some time tonographic studies and provocative tests were regularly performed, but they were abandoned when it was recognised that these have limited-if any-prognostic value, both from our own experience and that of others (Linner and Stromberg, 1964; Armaly, 1969; Graham, 1972; Kronfeld, 1975) .
In 34 patients (67 eyes) we did not treat the raised intraocular pressure; the remaining 27 patients (50 eyes) were treated. The latter are patients with an initial intraocular pressure of at least 35 mmHg, ocular hypertension which is present in an only eye, and, thirdly, a randomly selected group of patients with intraocular pressure below 30 mmHg who were placed on treatment as part of this prospective study to evaluate the influence of treatment on the natural history of the condition.
The treatment is pilocarpine (2, 3, or 4 %) 3 to 4 times daily, with adrenaline 20% twice daily added when necessary. A few patients are also on acetazolamide.
Before beginning treatment, however, all patients had their pupils dilated, and a careful search was made for equatorial lattice degeneration or holes in the retina. Peripheral retinal holes were found in 1 patient and these were closed by cryosurgery prior to the miotic treatment.
Results
There are 36 females and 25 males, and the average follow-up is 42-8 months. Of the 117 eyes 48 (41 %) have been followed up for more than 42 months, 69 (59 %) for more than 3 years, and 29 (25 %) for more than 5 years ( Fig. 1 ). (Fig. 2 ). There appears to be no significant correlation in the mean intraocular pressure with advancing age.
Twelve eyes of 10 patients (10-2%) developed glaucoma, i.e., pathological cupping of their discs and glaucomatous field defect. Visual field defects appeared after 12 to 60 months of follow-up in 11 of the 12 eyes and in 1 after 79 months, the mean being 41-3 months. Fig. 1 illustrates the relationship between the mean of the initial 3 intraocular pressure readings in each eye (follow-up in months), indicating also those eyes which developed glaucoma.
The highest pressure levels were measured in the age group 40 to 49, and it is in this decade that the highest incidence of glaucoma occurred (27-3 %) (Fig. 3) . In Fig. 4 Cup/disc ratio. Of the 12 eyes that developed glaucoma only 9 had accurate cup/disc measurements documented. Four of these had a cup/disc ratio of less than 0 5, and 5 had cup/disc ratio of 0 5 (1), 0 7 (2), and 0-8 (2). Influence of treatment on development ofglaucoma. Nine eyes (7 patients) developed glaucoma while on treatment. The response to treatment in the various pressure groups is shown in Table 2 , and the outcome of treatment in all patients in Table 3 . In Fig. 5 the relationship between mean intraocular pressure, length of follow-up, and the eyes which Table 4 shows the earliest noted pathological changes in the 12 eyes which developed glaucoma from ocular hypertension.
Discussion
Incidence of ocular hypertension progressing to glaucoma. The 10-2 % of glaucoma developing from ocular hypertension found in our series is higher than figures quoted by other authors (Graham, 1968; Armaly, 1969; Linner and Stromberg, 1967; and Perkins, 1973a) , but lower than the 20 % found by Walker (1974) .
The patients who developed glaucoma were slightly younger than the average age of the sample (mean age 55-2 years as compared with 62-1 years). This suggests that glaucoma occurring in a patient with ocular hypertension will become manifest early in the course of the ocular hypertension. In this series we noted that if glaucoma developed it did so usually within 5 years of the first presentation with ocular hypertension.
Earliest signs of glaucoma. In 7 cases the earliest sign of glaucoma was pathological cupping of the optic disc. This was confirmed by a matching defect on the Goldmann field (4 cases) or the Bjerrum screen (3 cases). The other 5 patients presented with nasal scotoma either peripheral (3) or paracentral (2) documented on the Goldmann perimeter (Table 4) While treatment did not prevent progression of ocular hypertension to glaucoma it did not, in this group of patients, do significant harm. The amount of cataract found in the treated group was similar to that in the untreated, and probably both were acceptable within the age-dependent incidence of cataract (Cinotti and Patti, 1968) .
Response to treatment. The response of the intraocular pressure to treatment is recorded in Fig. 6 as the mean drop in intraocular pressure after treatment. Most of the eyes that developed glaucoma had responded well to treatment (a drop of 11 mmHg or more) but also had high initial intraocular pressure. On the other hand many of the eyes (about one-third) that did not develop glaucoma also responded well to treatment. Therefore, in reading the results documented in Fig. 6 the effect of the initially high intraocular pressure is probably more important in determining progression to group.bmj.com on October 14, 2017 -Published by http://bjo.bmj.com/ Downloaded from glaucoma than is the response to treatment, but both factors appear to play a part.
The patients had their intraocular pressure monitored at 3-monthly intervals and were measured at different times during the day. The mean drop in intraocular pressure resulting from therapy in the treated group as a whole was 10-5 mmHg, the pressure dropping from a mean initial pressure of 31-6 mmHg to a mean pressure on treatment of 21-1 mmHg. In spite of this considerable drop in intraocular pressures these patients were not adequately protected from developing glaucoma, as 18% of them developed the disease. It also did not seem to postpone the onset of glaucoma, as glaucoma developed on average within 3j years.
The patients on treatment were not rigorously monitored in the sense of having regular diurnal variations of intraocular pressure measured at weekly or 2-weekly intervals to ensure that intraocular pressure was maintained under 20 mmHg at all times. It is possible but by no means certain that had such a rigorous regimen of control been followed these patients would have been adequately protected.
Our conclusion therefore is that, if the decision is made to treat a patient with ocular hypertension, then the ophthalmologist is committed to instituting treatment with a rigorous system of intraocular pressure control, by means of regular weekly or even daily (if the patient can do it himself) diurnal measurement of pressure to ensure that the intraocular pressure is constantly less than 20 mmHg. If this is not done then the patient is not protected against glaucoma.
If the intraocular pressure is not constantly maintained below 20 mmHg, either the medication must be increased, with the added risk of intensive medication, or the surgeon might as well abandon therapy. If intensive medication does not maintain intraocular pressure below 20 mmHg at all times of the diurnal curve, then the question of surgery arises. In our view ocular hypertensive patients run less risk if therapy is abandoned (only 10% of our patients developed glaucoma over 6 years, i.e., a 1-7 % annual risk) compared to the risk of surgery.
Three patients suffered a central vein occlusion during the follow-up period and deserve some attention. All had an intraocular pressure higher than 26 mmHg. Only 1 was on treatment at the time the occlusion occurred, and this patient was diabetic and had intraocular pressure readings of 36 mmHg prior to therapy. The other 2 received no treatment for their ocular hypertension, although I was hypertensive and on medical care.
As long-term pilocarpine treatment does not seem to be unduly harmful provided that degenerative retinal disease or retinal holes are treated prophylactically, it would seem reasonable that elderly patients (more than 70 years) with ocular hypertension and intraocular pressure measuring 26 mmHg or more should be treated in an attempt to improve perfusion at the optic head and to decrease the risk of vein occlusion. This is especially true if the patient has systemic vascular disease or is receiving antihypertensive drugs. On the other hand if the intraocular pressure does not respond to treatment with a fall of 5 mmHg or more, the treatment should be stopped.
Otherwise treatment seems to be unnecessary in ocular hypertension in which intraocular pressure without treatment is 30 mmHg or less, and can be postponed until frank glaucoma develops-if at all.
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